F&FFinancial Insights

Financial Metrics

GEHC GE HealthCare Technologies Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 4343000000.0 USD 10-Q 2023-04-25
Quarterly 2022-06-30 4484000000.0 +3.2% USD 10-Q 2023-07-25
Quarterly 2022-09-30 4576000000.0 +2.1% USD 10-Q 2023-10-31
Quarterly 2023-03-31 4707000000.0 +2.9% USD 10-Q 2024-04-30
Quarterly 2023-06-30 4817000000.0 +2.3% USD 10-Q 2024-07-31
Quarterly 2023-09-30 4822000000.0 +0.1% USD 10-Q 2024-10-30
Quarterly 2024-03-31 4650000000.0 -3.6% USD 10-Q 2025-04-30
Quarterly 2024-06-30 4839000000.0 +4.1% USD 10-Q 2025-07-30
Quarterly 2024-09-30 4863000000.0 +0.5% USD 10-Q 2025-10-29
Quarterly 2025-03-31 4777000000.0 -1.8% USD 10-Q 2025-04-30
Quarterly 2025-06-30 5007000000.0 +4.8% USD 10-Q 2025-07-30
Quarterly 2025-09-30 5143000000.0 +2.7% USD 10-Q 2025-10-29
Annual 2021-12-31 17585000000.0 USD 10-K 2024-02-06
Annual 2022-12-31 18341000000.0 +4.3% USD 10-K 2025-02-13
Annual 2023-12-31 19552000000.0 +6.6% USD 10-K 2026-02-04
Annual 2024-12-31 19672000000.0 +0.6% USD 10-K 2026-02-04
Annual 2025-12-31 20625000000.0 +4.8% USD 10-K 2026-02-04

Gross Profit

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 1678000000.0 USD 10-Q 2023-04-25
Quarterly 2022-06-30 1796000000.0 +7.0% USD 10-Q 2023-07-25
Quarterly 2022-09-30 1773000000.0 -1.3% USD 10-Q 2023-10-31
Quarterly 2023-03-31 1891000000.0 +6.7% USD 10-Q 2024-04-30
Quarterly 2023-06-30 1940000000.0 +2.6% USD 10-Q 2024-07-31
Quarterly 2023-09-30 1935000000.0 -0.3% USD 10-Q 2024-10-30
Quarterly 2024-03-31 1902000000.0 -1.7% USD 10-Q 2025-04-30
Quarterly 2024-06-30 2002000000.0 +5.3% USD 10-Q 2025-07-30
Quarterly 2024-09-30 2026000000.0 +1.2% USD 10-Q 2025-10-29
Quarterly 2025-03-31 2012000000.0 -0.7% USD 10-Q 2025-04-30
Quarterly 2025-06-30 1985000000.0 -1.3% USD 10-Q 2025-07-30
Quarterly 2025-09-30 1990000000.0 +0.3% USD 10-Q 2025-10-29
Annual 2021-12-31 7174000000.0 USD 10-K 2024-02-06
Annual 2022-12-31 7179000000.0 +0.1% USD 10-K 2025-02-13
Annual 2023-12-31 7922000000.0 +10.3% USD 10-K 2026-02-04
Annual 2024-12-31 8205000000.0 +3.6% USD 10-K 2026-02-04
Annual 2025-12-31 8248000000.0 +0.5% USD 10-K 2026-02-04

Operating Income

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 509000000.0 USD 10-Q 2023-04-25
Quarterly 2022-06-30 631000000.0 +24.0% USD 10-Q 2023-07-25
Quarterly 2022-09-30 605000000.0 -4.1% USD 10-Q 2023-10-31
Quarterly 2023-03-31 559000000.0 -7.6% USD 10-Q 2024-04-30
Quarterly 2023-06-30 570000000.0 +2.0% USD 10-Q 2024-07-31
Quarterly 2023-09-30 617000000.0 +8.2% USD 10-Q 2024-10-30
Quarterly 2024-03-31 540000000.0 -12.5% USD 10-Q 2025-04-30
Quarterly 2024-06-30 608000000.0 +12.6% USD 10-Q 2025-07-30
Quarterly 2024-09-30 676000000.0 +11.2% USD 10-Q 2025-10-29
Quarterly 2025-03-31 629000000.0 -7.0% USD 10-Q 2025-04-30
Quarterly 2025-06-30 654000000.0 +4.0% USD 10-Q 2025-07-30
Quarterly 2025-09-30 653000000.0 -0.2% USD 10-Q 2025-10-29
Annual 2021-12-31 2795000000.0 USD 10-K 2024-02-06
Annual 2022-12-31 2522000000.0 -9.8% USD 10-K 2025-02-13
Annual 2023-12-31 2435000000.0 -3.4% USD 10-K 2026-02-04
Annual 2024-12-31 2625000000.0 +7.8% USD 10-K 2026-02-04
Annual 2025-12-31 2763000000.0 +5.3% USD 10-K 2026-02-04

Net Income

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 402000000.0 USD 10-Q 2023-04-25
Quarterly 2022-06-30 498000000.0 +23.9% USD 10-Q 2023-07-25
Quarterly 2022-09-30 493000000.0 -1.0% USD 10-Q 2023-10-31
Quarterly 2023-03-31 383000000.0 -22.3% USD 10-Q 2024-04-30
Quarterly 2023-06-30 433000000.0 +13.1% USD 10-Q 2024-07-31
Quarterly 2023-09-30 382000000.0 -11.8% USD 10-Q 2024-10-30
Quarterly 2024-03-31 388000000.0 +1.6% USD 10-Q 2025-04-30
Quarterly 2024-06-30 435000000.0 +12.1% USD 10-Q 2025-07-30
Quarterly 2024-09-30 490000000.0 +12.6% USD 10-Q 2025-10-29
Quarterly 2025-03-31 588000000.0 +20.0% USD 10-Q 2025-04-30
Quarterly 2025-06-30 500000000.0 -15.0% USD 10-Q 2025-07-30
Quarterly 2025-09-30 464000000.0 -7.2% USD 10-Q 2025-10-29
Annual 2021-12-31 2293000000.0 USD 10-K 2024-02-06
Annual 2022-12-31 1967000000.0 -14.2% USD 10-K 2025-02-13
Annual 2023-12-31 1614000000.0 -17.9% USD 10-K 2026-02-04
Annual 2024-12-31 2050000000.0 +27.0% USD 10-K 2026-02-04
Annual 2025-12-31 2154000000.0 +5.1% USD 10-K 2026-02-04

EPS Basic

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 0.86 USD/shares 10-Q 2023-04-25
Quarterly 2022-06-30 1.07 +24.4% USD/shares 10-Q 2023-07-25
Quarterly 2022-09-30 1.07 +0.0% USD/shares 10-Q 2023-10-31
Quarterly 2023-03-31 0.42 -60.7% USD/shares 10-Q 2024-04-30
Quarterly 2023-06-30 0.92 +119.0% USD/shares 10-Q 2024-07-31
Quarterly 2023-09-30 0.82 -10.9% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 0.82 +0.0% USD/shares 10-Q 2025-04-30
Quarterly 2024-06-30 0.94 +14.6% USD/shares 10-Q 2025-07-30
Quarterly 2024-09-30 1.03 +9.6% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 1.23 +19.4% USD/shares 10-Q 2025-04-30
Quarterly 2025-06-30 1.06 -13.8% USD/shares 10-Q 2025-07-30
Quarterly 2025-09-30 0.98 -7.5% USD/shares 10-Q 2025-10-29
Annual 2021-12-31 4.95 USD/shares 10-K 2024-02-06
Annual 2022-12-31 4.22 -14.7% USD/shares 10-K 2025-02-13
Annual 2023-12-31 3.05 -27.7% USD/shares 10-K 2026-02-04
Annual 2024-12-31 4.37 +43.3% USD/shares 10-K 2026-02-04
Annual 2025-12-31 4.56 +4.3% USD/shares 10-K 2026-02-04

EPS Diluted

Q: 12 | A: 5

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2022-03-31 0.86 USD/shares 10-Q 2023-04-25
Quarterly 2022-06-30 1.07 +24.4% USD/shares 10-Q 2023-07-25
Quarterly 2022-09-30 1.07 +0.0% USD/shares 10-Q 2023-10-31
Quarterly 2023-03-31 0.41 -61.7% USD/shares 10-Q 2024-04-30
Quarterly 2023-06-30 0.91 +122.0% USD/shares 10-Q 2024-07-31
Quarterly 2023-09-30 0.82 -9.9% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 0.81 -1.2% USD/shares 10-Q 2025-04-30
Quarterly 2024-06-30 0.93 +14.8% USD/shares 10-Q 2025-07-30
Quarterly 2024-09-30 1.02 +9.7% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 1.23 +20.6% USD/shares 10-Q 2025-04-30
Quarterly 2025-06-30 1.06 -13.8% USD/shares 10-Q 2025-07-30
Quarterly 2025-09-30 0.98 -7.5% USD/shares 10-Q 2025-10-29
Annual 2021-12-31 4.95 USD/shares 10-K 2024-02-06
Annual 2022-12-31 4.22 -14.7% USD/shares 10-K 2025-02-13
Annual 2023-12-31 3.03 -28.2% USD/shares 10-K 2026-02-04
Annual 2024-12-31 4.34 +43.2% USD/shares 10-K 2026-02-04
Annual 2025-12-31 4.55 +4.8% USD/shares 10-K 2026-02-04

8-K Material Event Details

46 filings · 101 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

106 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-13 Lobo Kevin Dir Equity grant / award
A
Common Stock, par value $0.01 per share 777 $0.00 $0 777
2026-03-02 Bankes Jeannette CEO, Patient Care Solutions Equity grant / award
A · derivative
Employee Stock Option (right to buy) 18,038 $0.00 $0 18,038
2026-03-02 Bankes Jeannette CEO, Patient Care Solutions Equity grant / award
A
Common Stock, par value $0.01 per share 6,861 $0.00 $0 43,892
2026-02-12 Newcomb George A. Chief Accounting Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 802 $79.20 $63,518 9,318
2026-02-12 Newcomb George A. Chief Accounting Officer Equity grant / award
A
Common Stock, par value $0.01 per share 2,523 $0.00 $0 10,120
2026-02-01 O'Neill Kevin Michael CEO, PDx Other disposed transaction
F
Common Stock, par value $0.01 per share 462 $78.97 $36,484 22,518
2025-09-11 Rott Roland CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 1,614 $0.00 $0 0
2025-09-11 Rott Roland CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 3,727 $0.00 $0 0
2025-09-11 Rott Roland CEO, Imaging Other disposed transaction
F
Common Stock, par value $0.01 per share 1,352 $76.68 $103,671 29,122
2025-09-11 Rott Roland CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 1,614 $51.67 $83,395 30,474
2025-09-11 Rott Roland CEO, Imaging Other disposed transaction
F
Common Stock, par value $0.01 per share 3,268 $76.68 $250,590 28,860
2025-09-11 Rott Roland CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 3,727 $57.74 $215,197 32,128
2025-09-01 Stacherski Kenneth R. Chief Enterprise Oper. Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 434 $73.73 $31,999 40,996
2025-09-01 Stacherski Kenneth R. Chief Enterprise Oper. Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 458 $73.73 $33,768 41,430
2025-08-15 Stacherski Kenneth R. Chief Enterprise Oper. Officer Equity grant / award
A
Common Stock, par value $0.01 per share 10,217 $0.00 $0 41,888
2025-06-01 SACCARO JAMES Chief Financial Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 9,712 $70.54 $685,084 61,832
2025-05-28 LAVIZZO-MOUREY RISA J Dir Equity grant / award
A
Common Stock, par value $0.01 per share 3,092 $0.00 $0 10,157
2025-05-15 Bankes Jeannette CEO, Patient Care Solutions Equity grant / award
A · derivative
Employee Stock Option (right to buy) 18,754 $0.00 $0 18,754
2025-05-15 Bankes Jeannette CEO, Patient Care Solutions Equity grant / award
A
Common Stock, par value $0.01 per share 6,857 $0.00 $0 37,031
2025-05-15 Bankes Jeannette CEO, Patient Care Solutions Equity grant / award
A
Common Stock, par value $0.01 per share 30,174 $0.00 $0 30,174
2025-03-03 Newcomb George A. Chief Accounting Officer Equity grant / award
A · derivative
Employee Stock Option (right to buy) 3,307 $0.00 $0 3,307
2025-03-03 Newcomb George A. Chief Accounting Officer Equity grant / award
A
Common Stock, par value $0.01 per share 1,156 $0.00 $0 7,705
2025-03-03 Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Equity grant / award
A · derivative
Employee Stock Option (right to buy) 14,472 $0.00 $0 14,472
2025-03-03 Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Equity grant / award
A
Common Stock, par value $0.01 per share 5,060 $0.00 $0 31,671
2025-03-01 Newcomb George A. Chief Accounting Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 342 $87.35 $29,874 6,549
2025-02-18 Newcomb George A. Chief Accounting Officer Open-market sell
S
Common Stock, par value $0.01 per share 2,000 $92.54 $185,080 7,462
2025-02-06 Arduini Peter J President and CEO Equity grant / award
A
Common Stock, par value $0.01 per share 67,487 $0.00 $0 171,622
2025-02-02 Kass-Hout Taha Chief Technology Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 8,547 $88.30 $754,700 56,280
2025-02-01 SACCARO JAMES Chief Financial Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 934 $88.30 $82,472 60,266
2024-11-06 Rott Roland CEO, Imaging Open-market sell
S
Common Stock, par value $0.01 per share 3,577 $86.48 $309,339 24,298
2024-11-05 Rott Roland CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 13,275 $0.00 $0 0
2024-11-05 Rott Roland CEO, Imaging Other disposed transaction
F
Common Stock, par value $0.01 per share 9,698 $87.65 $850,030 27,875
2024-11-05 Rott Roland CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 13,275 $40.40 $536,310 37,573
2024-11-01 Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Other disposed transaction
F
Common Stock, par value $0.01 per share 11,028 $87.35 $963,296 27,055
2024-09-01 Rackliffe Philip CEO, Ultrasound & IGT Other disposed transaction
F
Common Stock, par value $0.01 per share 165 $84.82 $13,995 13,615
2024-09-01 Rackliffe Philip CEO, Ultrasound & IGT Other disposed transaction
F
Common Stock, par value $0.01 per share 1,388 $84.82 $117,730 13,780
2024-08-17 CULP H LAWRENCE JR Dir Other disposed transaction
F
Common Stock, par value $0.01 per share 291,053 $84.80 $24,681,294 333,021
2024-08-15 Holton Adam Y Chief People Officer Equity grant / award
A · derivative
Employee Stock Option (right to buy) 13,293 $0.00 $0 13,293
2024-08-15 Holton Adam Y Chief People Officer Equity grant / award
A
Common Stock, par value $0.01 per share 8,499 $0.00 $0 12,895
2024-08-15 Holton Adam Y Chief People Officer Equity grant / award
A
Common Stock, par value $0.01 per share 4,396 $0.00 $0 4,396
2024-08-14 Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Open-market sell
S
Common Stock, par value $0.01 per share 19,008 $83.22 $1,581,846 38,541
2024-08-07 Westrick Thomas J. CEO, Patient Care Solutions Open-market sell
S
Common Stock, par value $0.01 per share 2,750 $80.78 $222,145 17,509
2024-08-03 Rott Roland CEO, Imaging Other disposed transaction
F
Common Stock, par value $0.01 per share 1,630 $83.44 $136,007 22,199
2024-06-01 SACCARO JAMES Chief Financial Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 8,998 $78.00 $701,844 62,940
2024-05-28 Kass-Hout Taha Chief Technology Officer Open-market sell
S
Common Stock, par value $0.01 per share 3,300 $78.70 $259,710 67,300
2024-05-21 Yang Watkin Phoebe L. Dir Equity grant / award
A
Common Stock, par value $0.01 per share 2,440 $0.00 $0 6,024
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 33,095 $0.00 $0 33,096
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 25,472 $0.00 $0 0
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 8,388 $0.00 $0 0
2024-05-15 Makela Jan CEO, Imaging Open-market sell
S
Common Stock, par value $0.01 per share 66,955 $81.54 $5,459,511 63,348
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 33,095 $76.37 $2,527,465 130,303
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 25,472 $75.30 $1,918,042 97,208
2024-05-15 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 8,388 $63.51 $532,722 71,736
2024-05-13 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 20,227 $0.00 $0 8,388
2024-05-13 Makela Jan CEO, Imaging Open-market sell
S
Common Stock, par value $0.01 per share 20,227 $81.57 $1,649,916 63,348
2024-05-13 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 20,227 $63.51 $1,284,617 83,575
2024-05-01 Jimenez Frank R GC & Corporate Secretary Open-market buy
P
Common Stock, par value $0.01 per share 1,315 $76.52 $100,624 75,796
2024-04-01 Rott Roland CEO, Ultrasound Other disposed transaction
F
Common Stock, par value $0.01 per share 837 $90.91 $76,092 23,829
2024-03-15 GENERAL ELECTRIC CO Other disposed transaction
J
Common stock, par value $0.01 per share 14,000,000 32,631,302
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Equity grant / award
A · derivative
Employee Stock Option (right to buy) 8,435 $0.00 $0 8,435
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Equity grant / award
A
Common Stock, par value $0.01 per share 2,965 $0.00 $0 20,259
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 2,121 $91.28 $193,605 17,294
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 1,169 $91.28 $106,706 19,415
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 1,285 $91.28 $117,295 20,584
2024-03-01 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 1,195 $91.28 $109,080 21,869
2024-02-21 GENERAL ELECTRIC CO 10% Other disposed transaction
J
Common stock, par value $0.01 per share 14,950,000 46,631,302
2024-02-02 Kass-Hout Taha Chief Technology Officer Other disposed transaction
F
Common Stock, par value $0.01 per share 7,805 $74.35 $580,302 60,624
2023-11-01 Stacherski Kenneth R. Ch. Supply Chain & Serv. Ofc. Other disposed transaction
F
Common Stock, par value $0.01 per share 7,157 $67.23 $481,165 52,831
2023-08-03 Rott Roland CEO, Ultrasound Other disposed transaction
F
Common Stock, par value $0.01 per share 1,630 $76.19 $124,190 20,705
2023-07-31 O'Neill Kevin Michael CEO, PDx Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 13,275 $0.00 $0 0
2023-07-31 O'Neill Kevin Michael CEO, PDx Open-market sell
S
Common Stock, par value $0.01 per share 13,275 $77.46 $1,028,282 24,025
2023-07-31 O'Neill Kevin Michael CEO, PDx Exercise / conversion
M
Common Stock, par value $0.01 per share 13,275 $40.40 $536,310 37,300
2023-07-31 O'Neill Kevin Michael CEO, PDx Open-market sell
S
Common Stock, par value $0.01 per share 2,334 $76.55 $178,668 24,025
2023-07-01 Makela Jan CEO, Imaging Other disposed transaction
F
Common Stock, par value $0.01 per share 1,929 $80.36 $155,014 61,867
2023-06-23 GENERAL ELECTRIC CO 10% Other disposed transaction
J
Common stock, par value $0.01 per share 1,218,685 61,581,302
2023-06-14 GENERAL ELECTRIC CO 10% Other disposed transaction
J
Common stock, par value $0.01 per share 2,531,315 62,799,987
2023-06-12 GENERAL ELECTRIC CO 10% Other disposed transaction
J
Common stock, par value $0.01 per share 25,000,000 65,331,302
2023-06-08 Rott Roland CEO, Ultrasound Open-market sell
S
Common Stock, par value $0.01 per share 2,473 $77.37 $191,336 22,335
2023-06-01 SACCARO JAMES Chief Financial Officer Equity grant / award
A · derivative
Employee Stock Option (right to buy) 54,472 $4,348,500 54,472
2023-06-01 SACCARO JAMES Chief Financial Officer Equity grant / award
A · derivative
Employee Stock Option (right to buy) 36,176 $2,887,930 36,176
2023-06-01 SACCARO JAMES Chief Financial Officer Equity grant / award
A
Common Stock, par value $0.01 per share 5,950 $0.00 $0 61,693
2023-06-01 SACCARO JAMES Chief Financial Officer Equity grant / award
A
Common Stock, par value $0.01 per share 11,900 $0.00 $0 55,743
2023-06-01 SACCARO JAMES Chief Financial Officer Equity grant / award
A
Common Stock, par value $0.01 per share 43,843 $0.00 $0 43,843
2023-05-23 Mihaljevic Tomislav Dir Equity grant / award
A
Common Stock, par value $0.01 per share 3,584 $0.00 $0 3,584
2023-04-01 Rott Roland CEO, Ultrasound Other disposed transaction
F
Common Stock, par value $0.01 per share 837 $82.12 $68,734 24,808
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 4,037 $0.00 $0 0
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 54,701 $0.00 $0 0
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 5,967 $0.00 $0 0
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 240 $0.00 $0 0
2023-03-14 Makela Jan CEO, Imaging Open-market sell
S
Common Stock, par value $0.01 per share 5,684 $78.07 $443,750 63,796
2023-03-14 Makela Jan CEO, Imaging Open-market sell
S
Common Stock, par value $0.01 per share 64,945 $77.66 $5,043,629 69,480
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 4,037 $51.67 $208,592 134,425
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 54,701 $40.40 $2,209,920 130,388
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 5,967 $57.74 $344,535 75,687
2023-03-14 Makela Jan CEO, Imaging Exercise / conversion
M
Common Stock, par value $0.01 per share 240 $63.51 $15,242 69,720
2023-03-02 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 565 $75.04 $42,398 16,557
2023-03-01 Westrick Thomas J. CEO, Patient Care Solutions Equity grant / award
A · derivative
Employee Stock Option (right to buy) 10,188 $767,156 10,188
2023-03-01 Westrick Thomas J. CEO, Patient Care Solutions Other disposed transaction
F
Common Stock, par value $0.01 per share 1,039 $75.30 $78,237 17,122
2023-03-01 Westrick Thomas J. CEO, Patient Care Solutions Equity grant / award
A
Common Stock, par value $0.01 per share 3,652 $0.00 $0 18,161
2023-02-09 Newcomb George A. Chief Accounting Officer Equity grant / award
A
Common Stock, par value $0.01 per share 3,036 $0.00 $0 11,024
2023-02-01 Zodl Helmut Chief Financial Officer Equity grant / award
A · derivative
Employee Stock Option (right to buy) 47,031 $3,292,640 47,031
2023-02-01 Zodl Helmut Chief Financial Officer Equity grant / award
A
Common Stock, par value $0.01 per share 5,356 $0.00 $0 48,275
2023-01-23 CULP H LAWRENCE JR Dir Open-market buy
P
Common Stock, par value $0.01 per share 748 $69.26 $51,806 1,272
2023-01-04 Larson Betty D Chief People Officer Equity grant / award
A · derivative
Restricted Stock Units 32,779 32,779
2023-01-04 Larson Betty D Chief People Officer Equity grant / award
A · derivative
Restricted Stock Units 16,389 16,389
2023-01-03 LESJAK CATHERINE A Dir Equity grant / award
A · derivative
Deferred Fee Phantom Stock Units 3,192 3,192

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
13
Material Event Filings (8-K) — 12 months
12

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.